Size of the direct-to-consumer genomic testing market

Genet Med. 2010 Sep;12(9):594. doi: 10.1097/GIM.0b013e3181ead743.

Abstract

There has been enormous interest in the recent development of consumer genomics services, but very little is known about their impact. Using publicly available information, we estimate that the market for genetic susceptibility tests for complex diseases is much smaller than previously suggested, and hence consider that regulation through restrictive statutory legislation may be excessive.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Consumer Advocacy
  • Genetic Predisposition to Disease
  • Genetic Privacy
  • Genetic Testing / legislation & jurisprudence*
  • Genetic Testing / methods
  • Genetic Testing / trends
  • Genome, Human
  • Genomics / methods
  • Humans
  • Marketing of Health Services